Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial

Cezar Giosan, Cristina Mogoaşe, Oana Cobeanu, Aurora Szentágotai Tătar, Vlad Mureşan, Rareș Boian, Cezar Giosan, Cristina Mogoaşe, Oana Cobeanu, Aurora Szentágotai Tătar, Vlad Mureşan, Rareș Boian

Abstract

Background: Depression is a major challenge worldwide, with significant increasing personal, economic, and societal costs. Although empirically supported treatments have been developed, they are not always available for patients in routine clinical care. Therefore, we need effective and widely accessible strategies to prevent the onset of the very first depressive symptoms. Mental health apps could prove a valuable solution for this desideratum. Although preliminary research has indicated that such apps can be useful in treating depression, no study has attempted to test their utility in preventing depressive symptoms. The aim of this exploratory study is to contrast the efficacy of a smartphone app in reducing cognitive vulnerability and mild depressive symptoms, as risk factors for the onset of depression, against a wait-list condition. More specifically, we aim to test an app designed to (1) decrease general cognitive vulnerability and (2) promote engagement in protective, adaptive activities, while (3) counteracting (through gamification and customization) the tendency of premature dropout from intervention.

Methods/design: Romanian-speaking adults (18 years and older) with access to a computer and the Internet and who own a smartphone are included in the study. Two parallel randomized clinical trials are conducted: in the first one, 50 participants free of depressive symptoms (i.e., who obtain scores ≤4 on the Patient Health Questionnaire, PHQ-9) will be included, while in the second one 50 participants with minimal depressive symptoms (i.e., who obtain PHQ-9 scores between 5 and 9) will be included. Participants undergoing therapy, presenting with substance abuse problems, psychotic symptoms, and organic brain disorders, or serious legal or health issues that would prevent them from using the app, as well as participants reporting suicidal ideation are excluded. Participants randomized to the active intervention will autonomously use the smartphone app for 4 weeks, while the others will be given access to the app after 4 weeks from randomization. The primary outcomes are (1) cognitive vulnerability factors as defined within the cognitive behavioral therapy (CBT) paradigm (i.e., dysfunctional cognitions, irrational beliefs, and negative automatic thoughts) (for the first trial), and (2) level of depressive symptomatology (for the second trial). The app includes self-help materials and exercises based on CBT for depression, presented in a tailored manner and incorporating gamification elements aimed at boosting motivation to use the app.

Discussion: This study protocol is the first to capitalize on the ubiquity of smartphones to large-scale dissemination of CBT-based strategies aimed at preventing depression in non-clinical populations.

Trial registration: ClinicalTrials.gov: NCT02783118 . Registered on 26 May 2016.

Keywords: CBT; Depression; Prevention; Protocol; Randomized trial; Smartphone app.

Figures

Fig. 1
Fig. 1
App screenshot showing an example of the profile and overview section
Fig. 2
Fig. 2
App screenshots showing the “Find irrational beliefs exercise”
Fig. 3
Fig. 3
CONSORT flow diagram [49] showing subject allocation to the study conditions
Fig. 4
Fig. 4
Schedule of enrollment, interventions, and assessments. *t1x and t2x represent weekly separate assessments

References

    1. World Health Organization. Depression. 2016. . Accessed 8 Apr 2016.
    1. World Health Organization. Policies and practices for mental health in Europe. Meeting the challenges. 2016. . Accessed 8 Apr 2016.
    1. Ferrari AJ, Charlson FJ, Norman RE, Patten SB, Freedman G, Murray CJL, Vos T, Whiteford HA. Burden of depressive disorders by country, sex, age, and year: findings from the Global Burden of Disease study 2010. PLoS Med. 2013;10:e1001547. doi: 10.1371/journal.pmed.1001547.
    1. World Health Organization. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. 2011. . Accessed 14 Apr 2016.
    1. Greenberg PE, Kessler RC, Birnbaum HG, Leong SA, Lowe SW, Berglund PA, Corey-Lisle PK. The economic burden of depression in the United States: how did it change between 1990 and 2000? J Clin Psychiatry. 2003;64:1465–1475. doi: 10.4088/JCP.v64n1211.
    1. Olesen J, Gustavsson A, Svensson M, Wittchen H-U, Jönsson B. The economic cost of brain disorders in Europe. Eur J Neurol. 2012;19:155–162. doi: 10.1111/j.1468-1331.2011.03590.x.
    1. Sobocki P, Jönsson B, Angst J, Rehnberg C. Cost of depression in Europe. J Ment Health Policy Econ. 2006;9:87–98.
    1. Cuijpers P, Sijbrandij M, Koole SL, Andersson G, Beekman AT, Reynolds CF. The efficacy of psychotherapy and pharmacotherapy in treating depressive and anxiety disorders: a meta-analysis of direct comparisons. World Psychiatry. 2013;12:137–148. doi: 10.1002/wps.20038.
    1. Hofmann SG, Asnaani A, Vonk IJJ, Sawyer AT, Fang A. The efficacy of cognitive behavioral therapy: a review of meta-analyses. Cogn Ther Res. 2012;36:427–440. doi: 10.1007/s10608-012-9476-1.
    1. Greenberg PE, Fournier A-A, Sisitsky T, Pike CT, Kessler RC. The economic burden of adults with major depressive disorder in the United States (2005 and 2010) J Clin Psychiatry. 2015;76:155–162. doi: 10.4088/JCP.14m09298.
    1. Hidaka BH. Depression as a disease of modernity: explanations for increasing prevalence. J Affect Disord. 2012;140:205–214. doi: 10.1016/j.jad.2011.12.036.
    1. Lépine J-P, Briley M. The increasing burden of depression. Neuropsychiatr Dis Treat. 2011;7(Suppl 1):3–7.
    1. Cuijpers P. The patient perspective in research on major depression. BMC Psychiatry. 2011;11:89. doi: 10.1186/1471-244X-11-89.
    1. Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. J Gen Intern Med. 1999;14:569–580. doi: 10.1046/j.1525-1497.1999.03478.x.
    1. Cuijpers P, Smit F. Subthreshold depression as a risk indicator for major depressive disorder: a systematic review of prospective studies. Acta Psychiatr Scand. 2004;109:325–331. doi: 10.1111/j.1600-0447.2004.00301.x.
    1. Fava GA, Park SK, Sonino N. Treatment of recurrent depression. Expert Rev Neurother. 2006;6:1735–1740. doi: 10.1586/14737175.6.11.1735.
    1. Limosin F, Mekaoui L, Hautecouverture S. Stratégies thérapeutiques prophylactiques dans la dépression unipolaire. Presse Med. 2007;36(11, Part 2):1627–1633. doi: 10.1016/j.lpm.2007.03.032.
    1. Boland R, Keller M. Course and outcome of depression. In: Gotlib IH, Hammen HL, editors. Handbook of Depression. 2. New York: Guilford Press; 2009.
    1. Gartlehner G, Hansen RA, Thieda P, DeVeaugh-Geiss AM, Gaynes BN, Krebs EE, Lux LJ, Morgan LC, Shumate JA, Monroe LG, Lohr KN. Comparative effectiveness of second-generation antidepressants in the pharmacologic treatment of adult depression. Rockville: Agency for Healthcare Research and Quality (US); 2007.
    1. DeRubeis RJ, Hollon SD, Amsterdam JD, Shelton RC, Young PR, Salomon RM, O’Reardon JP, Lovett ML, Gladis MM, Brown LL, Gallop R. Cognitive therapy vs medications in the treatment of moderate to severe depression. Arch Gen Psychiatry. 2005;62:409–416. doi: 10.1001/archpsyc.62.4.409.
    1. Cuijpers P, Beekman ATF, Reynolds CF. Preventing depression. JAMA. 2012;307:1033–1034. doi: 10.1001/jama.2012.271.
    1. Muñoz RF, Beardslee WR, Leykin Y. Major depression can be prevented. Am Psychol. 2012;67:285–295. doi: 10.1037/a0027666.
    1. Buntrock C, Ebert DD, Lehr D, Smit F, Riper H, Berking M, Cuijpers P. Effect of a web-based guided self-help intervention for prevention of major depression in adults with subthreshold depression: a randomized clinical trial. JAMA. 2016;315:1854–1863. doi: 10.1001/jama.2016.4326.
    1. Beck AT. Thinking and depression: I. idiosyncratic content and cognitive distortions. Arch Gen Psychiatry. 1963;9:324–333. doi: 10.1001/archpsyc.1963.01720160014002.
    1. Beck AT. Cognitive therapy and the emotional disorders. New York: International Universities Press; 1976.
    1. Ellis A. Rational psychotherapy and individual psychology. J Individ Psychol. 1957;13:38–44.
    1. Haeffel GJ, Rozek DC, Hames JL, Technow J. Too much of a good thing: testing the efficacy of a cognitive bias modification task for cognitively vulnerable individuals. Cogn Ther Res. 2011;36:493–501. doi: 10.1007/s10608-011-9379-6.
    1. World Health Organization. Mental Health Action Plan: 2013–2020. . Accessed 11 Apr 2016.
    1. Birney AJ, Gunn R, Russell JK, Ary DV. MoodHacker mobile Web app with email for adults to self-manage mild-to-moderate depression: randomized controlled trial. JMIR Mhealth Uhealth. 2016;4(1):e8. doi: 10.2196/mhealth.4231.
    1. Burns MN, Begale M, Duffecy J, Gergle D, Karr CJ, Giangrande E, Mohr DC. Harnessing context sensing to develop a mobile intervention for depression. J Med Internet Res. 2011;13:e55. doi: 10.2196/jmir.1838.
    1. Kauer SD, Reid SC, Crooke AHD, Khor A, Hearps SJC, Jorm AF, Sanci L, Patton G. Self-monitoring using mobile phones in the early stages of adolescent depression: Randomized controlled trial. J Med Internet Res. 2012;14:e67. doi: 10.2196/jmir.1858.
    1. Proudfoot J, Clarke J, Birch M-R, Whitton AE, Parker G, Manicavasagar V, Harrison V, Christensen H, Hadzi-Pavlovic D. Impact of a mobile phone and web program on symptom and functional outcomes for people with mild-to-moderate depression, anxiety and stress: a randomised controlled trial. BMC Psychiatry. 2013;13:312. doi: 10.1186/1471-244X-13-312.
    1. Reid SC, Kauer SD, Khor AS, Hearps SJC, Sanci LA, Kennedy AD, Patton GC. Using a mobile phone application in youth mental health — an evaluation study. Aust Fam Physician. 2012;41:711–714.
    1. Watts S, Mackenzie A, Thomas C, Griskaitis A, Mewton L, Williams A, Andrews G. CBT for depression: a pilot RCT comparing mobile phone vs. computer. BMC Psychiatry. 2013;13:49. doi: 10.1186/1471-244X-13-49.
    1. Anthes E. Mental health: there’s an app for that. Nature. 2016;532:20–23. doi: 10.1038/532020a.
    1. Haeffel GJ, Grigorenko EL. Cognitive vulnerability to depression: exploring risk and resilience. Child Adolesc Psychiatr Clin N Am. 2007;16:435–448. doi: 10.1016/j.chc.2006.11.005.
    1. Alloy LB, Abramson LY, Whitehouse WG, Hogan ME, Panzarella C, Rose DT. Prospective incidence of first onsets and recurrences of depression in individuals at high and low cognitive risk for depression. J Abnorm Psychol. 2006;115:145–156. doi: 10.1037/0021-843X.115.1.145.
    1. Muñoz RF, Cuijpers P, Smit F, Barrera AZ, Leykin Y. Prevention of major depression. Annu Rev Clin Psychol. 2010;6:181–212. doi: 10.1146/annurev-clinpsy-033109-132040.
    1. Bakker D, Kazantzis N, Rickwood D, Rickard N. Mental health smartphone apps: review and evidence-based recommendations for future developments. JMIR Ment Health. 2016;3:e7. doi: 10.2196/mental.4984.
    1. Dobson D, Dobson KS. Evidence-based practice of cognitive-behavioral therapy. New York: Guilford Press; 2009.
    1. Rohde P, Stice E, Shaw H, Brière FN. Indicated cognitive behavioral group depression prevention compared to bibliotherapy and brochure control: acute effects of an effectiveness trial with adolescents. J Consult Clin Psychol. 2014;82:65–74. doi: 10.1037/a0034640.
    1. Christensen H, Griffiths KM, Farrer L. Adherence in Internet interventions for anxiety and depression. J Med Internet Res. 2009;11:e13. doi: 10.2196/jmir.1194.
    1. Kaltenthaler E, Parry G, Beverley C, Ferriter M. Computerised cognitive-behavioural therapy for depression: systematic review. Br J Psychiatry J Ment Sci. 2008;193:181–184. doi: 10.1192/bjp.bp.106.025981.
    1. So M, Yamaguchi S, Hashimoto S, Sado M, Furukawa TA, McCrone P. Is computerised CBT really helpful for adult depression? A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity. BMC Psychiatry. 2013;13:113. doi: 10.1186/1471-244X-13-113.
    1. Andrews G, Cuijpers P, Craske MG, McEvoy P, Titov N. Computer therapy for the anxiety and depressive disorders is effective, acceptable and practical health care: a meta-analysis. PLoS ONE. 2010;5:e13196. doi: 10.1371/journal.pone.0013196.
    1. Richardson T, Stallard P, Velleman S. Computerised cognitive behavioural therapy for the prevention and treatment of depression and anxiety in children and adolescents: a systematic review. Clin Child Fam Psychol Rev. 2010;13:275–290. doi: 10.1007/s10567-010-0069-9.
    1. Dryden W, DiGiuseppe R. A primer on rational-emotive therapy. Champaign: Research Press; 1990.
    1. Ellis A, Dryden W, DiGiuseppe R. The practice of rational emotive behavior therapy. New York: Springer Publishing Company; 2007.
    1. Schulz KF, Altman DG, Moher D, for the CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c332. doi: 10.1136/bmj.c332.
    1. Chan A-W, Tetzlaff JM, Altman DG, Laupacis A, Gøtzsche PC, Krleža-Jerić K, Hróbjartsson A, Mann H, Dickersin K, Berlin JA, Doré CJ, Parulekar WR, Summerskill WSM, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013;158:200–207. doi: 10.7326/0003-4819-158-3-201302050-00583.
    1. Crutzen R, De Nooijer J, Brouwer W, Oenema A, Brug J, De Vries NK. A conceptual framework for understanding and improving adolescents’ exposure to Internet-delivered interventions. Health Promot Int. 2009;24:277–284. doi: 10.1093/heapro/dap018.
    1. Ritterband LM, Thorndike FP, Cox DJ, Kovatchev BP, Gonder-Frederick LA. A behavior change model for Internet interventions. Ann Behav Med. 2009;38:18–27. doi: 10.1007/s12160-009-9133-4.
    1. Zichermann G, Cunningham C. Gamification by design: implementing game mechanics in web and mobile apps. Sebastopol: O’Reilly Media; 2011.
    1. Ellis A. Reason and emotion in psychotherapy. Secaucus: Carol Publishing Group; 1994.
    1. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV (SCID) Washington, DC: American Psychological Association; 1997.
    1. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: Validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606–613. doi: 10.1046/j.1525-1497.2001.016009606.x.
    1. First MB, Spitzer RB, Gibbon M, Williams JBW. Interviu Clinic Structurat Pentru Tulburarile Clinice de Pe Axa 1 a DSM — Versiune Clinica. Cluj-Napoca: Romanian Psychological Testing Services; 2007.
    1. American Psychiatric Association . Diagnostic and statistical manual of mental disorders. 4. Arlington: American Psychiatric Pub; 2000.
    1. Eaton W, Muntaner C, Smith C, Tien A, Ybarra M. Center for Epidemiologic Studies Depression Scale: Review and revision (CESD and CESD-R) In: Maruish M, editor. The use of psychological testing for treatment planning and outcomes assessment. 3. Mahwah: Lawrence Erlbaum; 2004. pp. 363–374.
    1. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385–401. doi: 10.1177/014662167700100306.
    1. Van Dam NT, Earleywine M. Validation of the Center for Epidemiologic Studies Depression Scale—Revised (CESD-R): pragmatic depression assessment in the general population. Psychiatry Res. 2011;186:128–132. doi: 10.1016/j.psychres.2010.08.018.
    1. Watson D, Clark LA, Tellegen A. Development and validation of brief measures of positive and negative affect: the PANAS scales. J Pers Soc Psychol. 1988;54:1063–1070. doi: 10.1037/0022-3514.54.6.1063.
    1. Cristea IA, Matu S, Szentagotai Tătar A, David D. The other side of rumination: reflective pondering as a strategy for regulating emotions in social situations. Anxiety Stress Coping. 2013;26:584–594. doi: 10.1080/10615806.2012.725469.
    1. Levine EL, Xu X, Yang L-Q, Ispas D, Pitariu HD, Bian R, Ding D, Capotescu R, Che H, Musat S. Cross-national explorations of the impact of affect at work using the State-Trait Emotion Measure: a coordinated series of studies in the United States, China, and Romania. Hum Perform. 2011;24:405–442. doi: 10.1080/08959285.2011.614302.
    1. Diener E, Emmons RA, Larsen RJ, Griffin S. The Satisfaction With Life Scale. J Pers Assess. 1985;49:71–75. doi: 10.1207/s15327752jpa4901_13.
    1. Pavot W, Diener E, Colvin CR, Sandvik E. Further validation of the Satisfaction with Life Scale: evidence for the cross-method convergence of well-being measures. J Pers Assess. 1991;57:149–161. doi: 10.1207/s15327752jpa5701_17.
    1. Pavot W, Diener E. Review of the Satisfaction With Life Scale. Psychol Assess. 1993;5:164–172. doi: 10.1037/1040-3590.5.2.164.
    1. Weissman AN, Beck AT: Development and validation of the Dysfunctional Attitude Scale: a preliminary investigation. Paper presented at the 62nd Annual Meeting of the American Educational Research Association, Toronto, Ontario, Canada, March 27–31, 1978.
    1. de Graaf LE, Roelofs J, Huibers MJH. Measuring dysfunctional attitudes in the general population: The Dysfunctional Attitude Scale (form A) Revised. Cogn Ther Res. 2009;33:345–355. doi: 10.1007/s10608-009-9229-y.
    1. Malouff JM, Schutte NS. Development and validation of a measure of irrational belief. J Consult Clin Psychol. 1986;54:860–862. doi: 10.1037/0022-006X.54.6.860.
    1. Malouff JM, Valdenegro J, Schutte NS. Further validation of a measure of irrational belief. J Ration Emotive Ther. 1987;5:189–193. doi: 10.1007/BF01080527.
    1. Hollon SD, Kendall PC. Cognitive self-statements in depression: development of an automatic thoughts questionnaire. Cogn Ther Res. 1980;4:383–395. doi: 10.1007/BF01178214.
    1. Harrell TH, Ryon NB. Cognitive-behavioral assessment of depression: clinical validation of the automatic thoughts questionnaire. J Consult Clin Psychol. 1983;51:721–725. doi: 10.1037/0022-006X.51.5.721.
    1. David D. Scale de Evaluare Clinică. Cluj Napoca: Romanian Psychological Testing Services; 2007.
    1. Moldovan R, Cobeanu O, David D. Cognitive bibliotherapy for mild depressive symptomatology: randomized clinical trial of efficacy and mechanisms of change. Clin Psychol Psychother. 2013;20:482–493. doi: 10.1002/cpp.1814.
    1. Vîslă A, Cristea IA, Szentágotai Tătar A, David D. Core beliefs, automatic thoughts and response expectancies in predicting public speaking anxiety. Personal Individ Differ. 2013;55:856–859. doi: 10.1016/j.paid.2013.06.003.
    1. Kanter JW, Mulick PS, Busch AM, Berlin KS, Martell CR. The Behavioral Activation for Depression Scale (BADS): psychometric properties and factor structure. J Psychopatol Behav Assess. 2007;29:191–202. doi: 10.1007/s10862-006-9038-5.
    1. Manos RC, Kanter JW, Luo W. The Behavioral Activation for Depression Scale-Short Form: development and validation. Behav Ther. 2011;42:726–739. doi: 10.1016/j.beth.2011.04.004.
    1. BineDispus Study - official webpage. .
    1. Billingham SA, Whitehead AL, Julious SA. An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database. BMC Med Res Methodol. 2013;13:104. doi: 10.1186/1471-2288-13-104.
    1. Ly KH, Topooco N, Cederlund H, Wallin A, Bergström J, Molander O, Carlbring P, Andersson G. Smartphone-supported versus full behavioural activation for depression: a randomised controlled trial. PLoS One. 2015;10:e0126559. doi: 10.1371/journal.pone.0126559.
    1. Project Dcombat: A Computerized Preventative and Therapeutic Intervention for Depression. .
    1. CDC. Burden of mental illness - mental illness - mental health basics - mental health. 2013. . Accessed 14 Apr 2016.
    1. Kessler RC, Zhao S, Blazer DG, Swartz M. Prevalence, correlates, and course of minor depression and major depression in the national comorbidity survey. J Affect Disord. 1997;45:19–30. doi: 10.1016/S0165-0327(97)00056-6.
    1. Preisig M, Merikangas KR, Angst J. Clinical significance and comorbidity of subthreshold depression and anxiety in the community. Acta Psychiatr Scand. 2001;104:96–103. doi: 10.1034/j.1600-0447.2001.00284.x.
    1. Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ. A descriptive analysis of minor depression. Am J Psychiatry. 2002;159:637–643. doi: 10.1176/appi.ajp.159.4.637.
    1. Rodríguez MR, Nuevo R, Chatterji S, Ayuso-Mateos JL. Definitions and factors associated with subthreshold depressive conditions: a systematic review. BMC Psychiatry. 2012;12:181. doi: 10.1186/1471-244X-12-181.
    1. Fergusson DM, Horwood LJ, Ridder EM, Beautrais AL. Subthreshold depression in adolescence and mental health outcomes in adulthood. Arch Gen Psychiatry. 2005;62:66–72. doi: 10.1001/archpsyc.62.1.66.
    1. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L, Norquist G, Howland RH, Lebowitz B, McGrath PJ, Shores-Wilson K, Biggs MM, Balasubramani GK, Fava M, STAR*D Study Team Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry. 2006;163:28–40. doi: 10.1176/appi.ajp.163.1.28.
    1. Donker T, Petrie K, Proudfoot J, Clarke J, Birch M-R, Christensen H. Smartphones for smarter delivery of mental health programs: a systematic review. J Med Internet Res. 2013;15(11):e247. doi: 10.2196/jmir.2791.

Source: PubMed

Sponsorer og samarbejdspartnere

Medicinske tilstande

Narkotikainterventioner

3
Abonner